{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/RYTM/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:10:10.203Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9102,"canonical_name":"RHYTHM PHARMACEUTICALS, INC.","cik":"0001649904","uei":null,"lei":null,"duns":null,"ticker":"RYTM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":54},"count":54,"timeline":[{"ts":"2026-10-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — RHYTHM PHARMACEUTICALS, INC. — 2026-10-13","url_slug":"/sec/cik-0001649904/schedule-13g/0000019617-26-000351","accession_number":"0000019617-26-000351","importance":55},{"ts":"2026-09-14","kind":"sec.insider.30746","reporter":"Meeker David P","title":"President and CEO","shares":30746,"price_per_share":102.347,"usd_value":3146761,"security_title":"Common Stock","importance":18.146760862},{"ts":"2026-09-14","kind":"sec.insider.8698","reporter":"Meeker David P","title":"President and CEO","shares":8698,"price_per_share":103.43,"usd_value":899634,"security_title":"Common Stock","importance":15.89963414},{"ts":"2026-09-14","kind":"sec.insider.6439","reporter":"Meeker David P","title":"President and CEO","shares":6439,"price_per_share":101.7464,"usd_value":655145,"security_title":"Common Stock","importance":15.6551450696},{"ts":"2026-09-14","kind":"sec.insider.50000","reporter":"Meeker David P","title":"President and CEO","shares":50000,"price_per_share":6.05,"usd_value":302500,"security_title":"Common Stock","importance":15.3025},{"ts":"2026-09-14","kind":"sec.insider.2300","reporter":"Meeker David P","title":"President and CEO","shares":2300,"price_per_share":105.19,"usd_value":241937,"security_title":"Common Stock","importance":15.241937},{"ts":"2026-09-14","kind":"sec.insider.1817","reporter":"Meeker David P","title":"President and CEO","shares":1817,"price_per_share":104.5487,"usd_value":189965,"security_title":"Common Stock","importance":15.1899649879},{"ts":"2026-08-18","kind":"sec.filing","form_type":"3","title":"3 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-18","url_slug":"/sec/cik-0001649904/3/0001649904-26-000018","accession_number":"0001649904-26-000018","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-18","url_slug":"/sec/cik-0001649904/4/0001649904-26-000020","accession_number":"0001649904-26-000020","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-17","url_slug":"/sec/cik-0001649904/4/0001649904-26-000013","accession_number":"0001649904-26-000013","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-17","url_slug":"/sec/cik-0001649904/4/0001649904-26-000015","accession_number":"0001649904-26-000015","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-14","url_slug":"/sec/cik-0001649904/4/0001649904-26-000007","accession_number":"0001649904-26-000007","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-14","url_slug":"/sec/cik-0001649904/4/0001649904-26-000009","accession_number":"0001649904-26-000009","importance":30},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Lee Jennifer Kayden","title":"EVP, Head of North America","shares":75834,"price_per_share":117.3818,"usd_value":8901531,"security_title":"Common Stock","importance":43.9015314212},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Shulman Joseph","title":"Chief Technical Officer","shares":5079,"price_per_share":119.75,"usd_value":608210,"security_title":"Common Stock","importance":35.60821025},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":3400,"price_per_share":118.2843,"usd_value":402167,"security_title":"Common Stock","importance":35.40216662},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":2007,"price_per_share":116.1093,"usd_value":233031,"security_title":"Common Stock","importance":35.2330313651},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":1556,"price_per_share":117.0759,"usd_value":182170,"security_title":"Common Stock","importance":35.1821701004},{"ts":"2026-08-13","kind":"sec.insider.s","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":800,"price_per_share":119.1688,"usd_value":95335,"security_title":"Common Stock","importance":35.09533504},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-13","url_slug":"/sec/cik-0001649904/144/0001950047-26-008093","accession_number":"0001950047-26-008093","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-13","url_slug":"/sec/cik-0001649904/144/0001950047-26-008094","accession_number":"0001950047-26-008094","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-13","url_slug":"/sec/cik-0001649904/144/0001950047-26-008100","accession_number":"0001950047-26-008100","importance":30},{"ts":"2026-08-13","kind":"sec.insider.m","reporter":"Lee Jennifer Kayden","title":"EVP, Head of North America","shares":35000,"price_per_share":24.29,"usd_value":850150,"security_title":"Common Stock","importance":15.85015},{"ts":"2026-08-13","kind":"sec.insider.m","reporter":"Lee Jennifer Kayden","title":"EVP, Head of North America","shares":21601,"price_per_share":6.8,"usd_value":146887,"security_title":"Common Stock","importance":15.1468868},{"ts":"2026-08-13","kind":"sec.insider.m","reporter":"Shulman Joseph","title":"Chief Technical Officer","shares":2024,"price_per_share":6.8,"usd_value":13763,"security_title":"Common Stock","importance":15.0137632},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":18208,"price_per_share":116.4941,"usd_value":2121125,"security_title":"Common Stock","importance":37.1211245728},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":17319,"price_per_share":117.4686,"usd_value":2034439,"security_title":"Common Stock","importance":37.0344386834},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":14568,"price_per_share":115.427,"usd_value":1681541,"security_title":"Common Stock","importance":36.681540536},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":3605,"price_per_share":114.6955,"usd_value":413477,"security_title":"Common Stock","importance":35.4134772775},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":2300,"price_per_share":111.7992,"usd_value":257138,"security_title":"Common Stock","importance":35.25713816},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":1000,"price_per_share":112.856,"usd_value":112856,"security_title":"Common Stock","importance":35.112856},{"ts":"2026-08-12","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-12","url_slug":"/sec/cik-0001649904/144/0001950047-26-008030","accession_number":"0001950047-26-008030","importance":30},{"ts":"2026-08-12","kind":"sec.insider.m","reporter":"Mazabraud Yann","title":"EVP, Head of International","shares":46625,"price_per_share":6.8,"usd_value":317050,"security_title":"Common Stock","importance":15.31705},{"ts":"2026-08-11","kind":"sec.form144","reporter":"PAMELA CRAMER","title":"Officer","shares":11406,"usd_value":1317165,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007962","importance":40.263432976},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-11","url_slug":"/sec/cik-0001649904/144/0001950047-26-007962","accession_number":"0001950047-26-007962","importance":30},{"ts":"2026-08-10","kind":"sec.filing","form_type":"144","title":"144 — RHYTHM PHARMACEUTICALS, INC. — 2026-08-10","url_slug":"/sec/cik-0001649904/144/0001950047-26-007889","accession_number":"0001950047-26-007889","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"10-Q","title":"10-Q — RHYTHM PHARMACEUTICALS, INC. — 2026-08-04","url_slug":"/sec/cik-0001649904/10-q/0001628280-26-052533","accession_number":"0001628280-26-052533","importance":45},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — RHYTHM PHARMACEUTICALS, INC. — 2026-08-04","url_slug":"/sec/cik-0001649904/8-k/0001628280-26-052170","accession_number":"0001628280-26-052170","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — RHYTHM PHARMACEUTICALS, INC. — 2026-07-02","url_slug":"/sec/cik-0001649904/4/0001104659-26-080397","accession_number":"0001104659-26-080397","importance":30},{"ts":"2026-07-01","kind":"sec.insider.f","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":2150,"price_per_share":110.41,"usd_value":237382,"security_title":"Common Stock","importance":15.2373815},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Garfield Alastair","title":"Chief Scientific Officer","shares":4445,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-25","kind":"sec.filing","form_type":"8-K","title":"8-K — RHYTHM PHARMACEUTICALS, INC. — 2026-06-25","url_slug":"/sec/cik-0001649904/8-k/0001628280-26-045569","accession_number":"0001628280-26-045569","importance":35},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"MCGIRR DAVID W J","title":"","shares":4712,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"GOOD JENNIFER L","title":"","shares":4712,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"JEAN CHRISTOPHE","title":"","shares":4712,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"Arbuckle Stuart A","title":"","shares":4712,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-23","kind":"sec.insider.m","reporter":"TETRAULT LYNN A.","title":"","shares":4712,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-22","kind":"sec.form144","reporter":"LYNN TETRAULT","title":"Director","shares":37000,"usd_value":3581230,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006392","importance":40.716246},{"ts":"2026-06-15","kind":"sec.filing","form_type":"8-K","title":"8-K — RHYTHM PHARMACEUTICALS, INC. — 2026-06-15","url_slug":"/sec/cik-0001649904/8-k/0001628280-26-043170","accession_number":"0001628280-26-043170","importance":35},{"ts":"2026-05-18","kind":"sec.insider.m","reporter":"Smith Hunter C","title":"Chief Financial Officer","shares":3000,"price_per_share":17.87,"usd_value":53610,"security_title":"Common Stock","importance":15.05361},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"German Christopher Paul","title":"Corporate Controller & CAO","shares":4643,"price_per_share":92.21,"usd_value":428131,"security_title":"Common Stock","importance":35.42813103},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"German Christopher Paul","title":"Corporate Controller & CAO","shares":1687,"price_per_share":56.69,"usd_value":95636,"security_title":"Common Stock","importance":15.09563603},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"German Christopher Paul","title":"Corporate Controller & CAO","shares":1349,"price_per_share":49.23,"usd_value":66411,"security_title":"Common Stock","importance":15.06641127},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"German Christopher Paul","title":"Corporate Controller & CAO","shares":1406,"price_per_share":17.97,"usd_value":25266,"security_title":"Common Stock","importance":15.02526582}]}